Diego Ferrer‐Pargada

410 total citations
26 papers, 187 citations indexed

About

Diego Ferrer‐Pargada is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Diego Ferrer‐Pargada has authored 26 papers receiving a total of 187 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Diego Ferrer‐Pargada's work include Long-Term Effects of COVID-19 (11 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and COVID-19 Clinical Research Studies (4 papers). Diego Ferrer‐Pargada is often cited by papers focused on Long-Term Effects of COVID-19 (11 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and COVID-19 Clinical Research Studies (4 papers). Diego Ferrer‐Pargada collaborates with scholars based in Spain, Denmark and Sweden. Diego Ferrer‐Pargada's co-authors include Manuel Herrero‐Montes, César Fernández‐de‐las‐Peñas, Paula Parás‐Bravo, Jorge Rodríguez‐Jiménez, Ignacio Cancela‐Cilleruelo, Lars Arendt‐Nielsen, Francisco Arnaíz de las Revillas, José Ramón Blanco, Julián Olalla and Lourdes Romero and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Diego Ferrer‐Pargada

24 papers receiving 184 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diego Ferrer‐Pargada Spain 6 122 58 41 40 37 26 187
Simone Turner Denmark 4 184 1.5× 114 2.0× 18 0.4× 35 0.9× 33 0.9× 5 257
Annalisa Frizzelli Italy 10 118 1.0× 76 1.3× 93 2.3× 21 0.5× 126 3.4× 33 319
Katherine Myall United Kingdom 7 224 1.8× 175 3.0× 33 0.8× 39 1.0× 183 4.9× 20 376
Marta Cilla Italy 8 68 0.6× 35 0.6× 28 0.7× 26 0.7× 13 0.4× 13 154
Valentina Sofia Italy 5 79 0.6× 61 1.1× 62 1.5× 26 0.7× 8 0.2× 6 179
Paolo Cirillo Italy 10 63 0.5× 38 0.7× 15 0.4× 8 0.2× 9 0.2× 29 281
Islam Galal Egypt 7 86 0.7× 59 1.0× 6 0.1× 20 0.5× 10 0.3× 10 142
Damien Basille France 7 36 0.3× 34 0.6× 32 0.8× 20 0.5× 87 2.4× 34 201
Demet Turan Türkiye 7 47 0.4× 23 0.4× 21 0.5× 17 0.4× 121 3.3× 42 219

Countries citing papers authored by Diego Ferrer‐Pargada

Since Specialization
Citations

This map shows the geographic impact of Diego Ferrer‐Pargada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Ferrer‐Pargada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Ferrer‐Pargada more than expected).

Fields of papers citing papers by Diego Ferrer‐Pargada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego Ferrer‐Pargada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Ferrer‐Pargada. The network helps show where Diego Ferrer‐Pargada may publish in the future.

Co-authorship network of co-authors of Diego Ferrer‐Pargada

This figure shows the co-authorship network connecting the top 25 collaborators of Diego Ferrer‐Pargada. A scholar is included among the top collaborators of Diego Ferrer‐Pargada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego Ferrer‐Pargada. Diego Ferrer‐Pargada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santis, Michele Andrea De, Diego Ferrer‐Pargada, Nadia Corcione, et al.. (2025). Enhancing diagnostic precision: a multicentric study of endobronchial ultrasound-guided transbronchial mediastinal cryobiopsy in lymphoproliferative disorders. ERJ Open Research. 11(5). 775–2024. 1 indexed citations
2.
Ferrer‐Pargada, Diego, Carlos Antonio Amado Diago, Beatriz Abascal-Bolado, et al.. (2025). FeNO as a biomarker of interstitial and fibrotic pulmonary sequelae in patients admitted for severe SARS-CoV-2 pneumonia. Scientific Reports. 15(1). 25696–25696. 1 indexed citations
3.
Ferrer‐Pargada, Diego, et al.. (2024). Flecainide-associated Pneumonitis, a Case Report: COVID is Not All That it Seems. SHILAP Revista de lepidopterología. 6(4). 100372–100372.
4.
Iturbe‐Fernández, David, Verónica Pulito‐Cueto, Víctor Manuel Mora Cuesta, et al.. (2024). Osteopontin as a Biomarker in Interstitial Lung Diseases. Biomedicines. 12(5). 1108–1108. 2 indexed citations
5.
Pulito‐Cueto, Verónica, Diego Ferrer‐Pargada, Sara Remuzgo‐Martínez, et al.. (2024). Inflammasome-Related Genetic Polymorphisms as Severity Biomarkers of COVID-19. International Journal of Molecular Sciences. 25(7). 3731–3731. 2 indexed citations
6.
Parás‐Bravo, Paula, César Fernández‐de‐las‐Peñas, Diego Ferrer‐Pargada, et al.. (2024). Serological Biomarkers in Individuals with Interstitial Lung Disease after SARS-CoV-2 Infection and Association with Post-COVID-19 Symptoms. Pathogens. 13(8). 641–641. 1 indexed citations
8.
Herrero‐Montes, Manuel, César Fernández‐de‐las‐Peñas, Diego Ferrer‐Pargada, et al.. (2023). Association of Kinesiophobia with Catastrophism and Sensitization-Associated Symptoms in COVID-19 Survivors with Post-COVID Pain. Diagnostics. 13(5). 847–847. 4 indexed citations
9.
Ramos‐Hernández, Cristina, Rosa Cordovilla, Ana Núñez Ares, et al.. (2023). Multicentre study on the accuracy of lung ultrasound in the diagnosis and monitoring of respiratory sequelae in the medium and long term in patients with COVID-19. Frontiers in Medicine. 10. 1199666–1199666. 3 indexed citations
10.
Diago, Carlos Antonio Amado, Bernardo Alio Lavín, Armando Ruiz, et al.. (2023). Circulating levels of mitochondrial oxidative stress-related peptides MOTS-c and Romo1 in stable COPD: A cross-sectional study. Frontiers in Medicine. 10. 1100211–1100211. 5 indexed citations
11.
Fernández‐de‐las‐Peñas, César, Juan Antonio Valera‐Calero, Manuel Herrero‐Montes, et al.. (2022). The Self-Reported Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) and PainDETECT Questionnaires in COVID-19 Survivors with Post-COVID Pain. Viruses. 14(7). 1486–1486. 12 indexed citations
12.
Fernández‐de‐las‐Peñas, César, Paula Parás‐Bravo, Diego Ferrer‐Pargada, et al.. (2022). Sensitization symptoms are associated with psychological and cognitive variables in COVID‐19 survivors exhibiting post‐COVID pain. Pain Practice. 23(1). 23–31. 17 indexed citations
13.
Herrero‐Montes, Manuel, César Fernández‐de‐las‐Peñas, Diego Ferrer‐Pargada, et al.. (2022). Prevalence of Neuropathic Component in Post‐COVID Pain Symptoms in Previously Hospitalized COVID‐19 Survivors. International Journal of Clinical Practice. 2022(1). 3532917–3532917. 28 indexed citations
14.
Fernández‐de‐las‐Peñas, César, Bernard X. W. Liew, Manuel Herrero‐Montes, et al.. (2022). Data-Driven Path Analytic Modeling to Understand Underlying Mechanisms in COVID-19 Survivors Suffering from Long-Term Post-COVID Pain: A Spanish Cohort Study. Pathogens. 11(11). 1336–1336. 3 indexed citations
15.
Fernández‐de‐las‐Peñas, César, Manuel Herrero‐Montes, Diego Ferrer‐Pargada, et al.. (2022). Sensitization-Associated Post-COVID-19 Symptoms at 6 Months Are Not Associated with Serological Biomarkers at Hospital Admission in COVID-19 Survivors: A Secondary Analysis of a Cohort Study. Journal of Clinical Medicine. 11(12). 3512–3512. 3 indexed citations
16.
Blanco, José Ramón, Francisco Arnaíz de las Revillas, Enrique Bernal, et al.. (2021). Pulmonary long-term consequences of COVID-19 infections after hospital discharge. Clinical Microbiology and Infection. 27(6). 892–896. 76 indexed citations
17.
Armiñanzas, Carlos, Francisco Arnaíz de las Revillas, Manuel Cuadra, et al.. (2021). Usefulness of the COVID-GRAM and CURB-65 scores for predicting severity in patients with COVID-19. International Journal of Infectious Diseases. 108. 282–288. 11 indexed citations
18.
Prieto-Peña, D., et al.. (2021). Coexisting sarcoidosis and systemic lupus erythematosus: a case report and literature review.. PubMed. 46(2). 177–185. 2 indexed citations
19.
Armiñanzas, Carlos, et al.. (2016). Papel de la bacteriobilia en las complicaciones postoperatorias. Revista española de quimioterapia. Suplemento. 29(3). 123–129. 1 indexed citations
20.
Diago, Carlos Antonio Amado, et al.. (2012). LL-37 is produced intrapleurally in infectious pleural effusion. 40. 2520. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026